The impact of acetylcholinesterase inhibitors on ileus and gut motility following abdominal surgery: a clinical review
Date
2022
Authors
Traeger, L.
Kroon, H.M.
Bedrikovetski, S.
Moore, J.W.
Sammour, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
ANZ Journal of Surgery, 2022; 92(1-2):69-76
Statement of Responsibility
Luke Traeger, Hidde M. Kroon, Sergei Bedrikovetski, James W. Moore, and Tarik Sammour
Conference Name
Abstract
Postoperative ileus is a common complication in the days following colorectal surgery occurring in up to 50% of patients. When prolonged, this complication results in significant morbidity and mortality, doubling the total costs of hospital stay. Postoperative ileus (POI) results from the prolonged inflammatory phase that is mediated in part by the cholinergic anti-inflammatory pathway. Acetylcholinesterase inhibitors, such as neostigmine and pyridostigmine, delay the degradation of acetylcholine at the synaptic cleft. This increase in acetylcholine has been shown to increase gut motility. They have been effective in the treatment of acute colonic pseudo-obstruction, but there is limited evidence for the use of these medications for reducing the incidence of POI. This review was conducted to summarise the evidence of acetylcholinesterase inhibitors’ effect on gut motility and discuss their potential use as part of an enhanced recovery protocols to prevent or treat POI.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2021 Royal Australasian College of Surgeons.